Drug Pricing ‘Watchdog’ Launches New Initiative With English, Canadian HTA Orgs

The U.S. nonprofit drug pricing watchdog ICER has joined forces with health technology assessment (HTA) groups in England and Canada to research new ways to evaluate the costs of prescription drugs, diagnostics and other health care interventions. The new independent international working group, Health Economics Methods Advisory (HEMA), is spearheaded by the U.S.-based Institute for Clinical and Economic Review (ICER), England’s National Institute for Health and Care Excellence (NICE) and Canada’s Drug Agency (CDA-AMC). The group was launched last month...